Vanguard Capital Management’s Artelo Biosciences ARTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.55K Buy
1,127
+2
+0.2% +$14 ﹤0.01% 4044
2026
Q2
$11.3K Hold
1,125
– – ﹤0.01% 4046
2026
Q1
$76.8K Buy
+1,125
New +$47.9K ﹤0.01% 3884

Other funds holding ARTL

Vanguard Capital Management's ARTL Position: Q3 2026 in Review

Vanguard Capital Management increased its Artelo Biosciences (ARTL) stake by 0.18% in Q3 2026, buying an estimated $14 and bringing the position to 1,127 shares worth $4.55K. The position accounts for ﹤0.01% of the portfolio, ranked #4044.

Vanguard Capital Management first reported a position in ARTL in Q1 2026 and has held it in 3 quarters since. The position peaked at $76.8K in Q1 2026. 8 funds tracked by Wall St. Rank hold ARTL as of Q3 2026.

  • Vanguard Capital Management held 1,127 shares of Artelo Biosciences worth $4.55K as of Q3 2026.
  • Vanguard Capital Management bought 2 Artelo Biosciences shares in Q3 2026, an estimated $14.
  • Artelo Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #4044 holding.
  • Vanguard Capital Management first reported a position in Artelo Biosciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Artelo Biosciences position peaked at $76.8K in Q1 2026.
  • 8 funds tracked by Wall St. Rank held Artelo Biosciences as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.